Biodesix (BDSX)
(Delayed Data from NSDQ)
$1.77 USD
-0.03 (-1.67%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $1.77 0.00 (0.00%) 5:28 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for Biodesix, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -52.15 | -65.45 | -43.16 | -31.35 | -30.73 |
Depreciation/Amortization & Depletion | 10.66 | 10.88 | 5.88 | 7.44 | 3.20 |
Net Change from Assets/Liabilities | 13.80 | -6.82 | 4.59 | -4.80 | -1.65 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.82 | 16.41 | 4.46 | 7.35 | 7.45 |
Net Cash From Operating Activities | -22.87 | -44.97 | -28.22 | -21.37 | -21.73 |
Property & Equipment | -22.92 | -3.30 | -2.24 | -1.95 | -1.42 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | -0.75 | -0.46 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.14 | -0.24 | -0.31 | -0.23 | 0.00 |
Net Cash from Investing Activities | -23.06 | -3.53 | -2.55 | -2.93 | -1.87 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 28.86 | 60.16 | 17.44 | 73.34 | 10.05 |
Issuance (Repayment) of Debt | 9.95 | 16.50 | -15.35 | 12.96 | 13.04 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 3.09 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -9.68 | -17.78 | -0.83 | -8.25 | -0.12 |
Net Cash from Financing Activities | 29.13 | 58.88 | 1.26 | 81.13 | 22.97 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -16.80 | 10.38 | -29.51 | 56.84 | -0.63 |
Cash at Beginning of Period | 43.17 | 32.80 | 62.31 | 5.47 | 6.09 |
Cash at End of Period | 26.37 | 43.17 | 32.80 | 62.31 | 5.47 |
Diluted Net EPS | -0.64 | -1.55 | -1.58 | -6.48 | NA |
Fiscal Year End for Biodesix, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -24.42 | -13.61 | -52.15 | -43.01 | -32.06 |
Depreciation/Amortization & Depletion | 2.78 | 2.45 | 10.66 | 8.18 | 5.68 |
Net Change from Assets/Liabilities | -18.66 | -6.93 | 13.80 | 18.04 | 15.87 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.42 | 2.78 | 4.82 | 6.21 | 3.76 |
Net Cash From Operating Activities | -33.88 | -15.31 | -22.87 | -10.59 | -6.75 |
Property & Equipment | -2.16 | -0.23 | -22.92 | -19.94 | -14.09 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -0.04 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.11 | 0.00 | -0.14 | -0.13 | -0.09 |
Net Cash from Investing Activities | -2.27 | -0.27 | -23.06 | -20.06 | -14.18 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 55.91 | 0.91 | 28.86 | 16.05 | 0.51 |
Issuance (Repayment) of Debt | -0.03 | -0.01 | 9.95 | -0.04 | -0.02 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -3.80 | -0.11 | -9.68 | -8.61 | -5.23 |
Net Cash from Financing Activities | 52.09 | 0.79 | 29.13 | 7.40 | -4.75 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 15.94 | -14.79 | -16.80 | -23.25 | -25.68 |
Cash at Beginning of Period | 26.37 | 26.37 | 43.17 | 43.17 | 43.17 |
Cash at End of Period | 42.31 | 11.58 | 26.37 | 19.93 | 17.50 |
Diluted Net EPS | -0.08 | -0.14 | -0.09 | -0.14 | -0.17 |